Feed VSBC
VS

VitaSpring Biomedical Co. Ltd.

VSBC · OTC

$0.01 +0.00% (+$0.00)
Market Cap $2.30M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
0 /100
Expensive
P/FCF 166.34x
P/B N/A
P/FFO N/A
Growth
-
N/A
Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A
FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
57 /100
Average
ROA 3,074.10%
Asset turnover 0.00x
ROIC 19.90%
Debt
0 /100
High
Current ratio 0.01x
Debt/Assets N/A
Net debt/EBITDA N/A
Stability
13 /100
Unstable
Profitable years 0
EPS volatility 754.24%
Beta -2.48x

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about VSBC
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Ssu-Chuan Lai

Employees

1

Headquarters

Riverside

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.